Ann W Silk

18PUBLICATIONS
73CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 03, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Tessa F Flores, Emily S Tonorezos, Shailender Bhatia

|Mar 22, 2025
A SITC vision: adapting clinical trials to accelerate drug development in cancer immunotherapy.

Thomas U Marron, Jason J Luke, Brianna Hoffner

|Sep 14, 2024
Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression.

Karam Khaddour, Naoka Murakami, Emily S Ruiz

|Aug 29, 2024
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab.

Anna K Maloney, Anita Giobbie-Hurder, Nikita Katukota

|Aug 05, 2024
Changes in Merkel cell oncoprotein antibodies after radiation therapy in curatively treated Merkel cell carcinoma and association with recurrence.

Kevin X Liu, Kee-Young Shin, Manisha Thakuria

|Jul 25, 2024
Circulating Tumor DNA Assay Detects Merkel Cell Carcinoma Recurrence, Disease Progression, and Minimal Residual Disease: Surveillance and Prognostic Implications.

Tomoko Akaike, Manisha Thakuria, Ann W Silk

Pageof 3

Frequent Collaborators

3 joint publications

Manisha Thakuria

3 joint publications

Shailender Bhatia

2 joint publications

Roman Groisberg

2 joint publications

Naoka Murakami